FR2263781A1 - - Google Patents

Info

Publication number
FR2263781A1
FR2263781A1 FR7325355A FR7325355A FR2263781A1 FR 2263781 A1 FR2263781 A1 FR 2263781A1 FR 7325355 A FR7325355 A FR 7325355A FR 7325355 A FR7325355 A FR 7325355A FR 2263781 A1 FR2263781 A1 FR 2263781A1
Authority
FR
France
Prior art keywords
antigen
antibody
serum hepatitis
blood
blood fluids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7325355A
Other languages
English (en)
French (fr)
Other versions
FR2263781B1 (US06724976-20040420-M00002.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of FR2263781A1 publication Critical patent/FR2263781A1/fr
Application granted granted Critical
Publication of FR2263781B1 publication Critical patent/FR2263781B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
FR7325355A 1972-07-13 1973-07-11 Expired FR2263781B1 (US06724976-20040420-M00002.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US271452A US3896218A (en) 1972-07-13 1972-07-13 Radiommunoassay determining the hepatitis associated antigen content of blood

Publications (2)

Publication Number Publication Date
FR2263781A1 true FR2263781A1 (US06724976-20040420-M00002.png) 1975-10-10
FR2263781B1 FR2263781B1 (US06724976-20040420-M00002.png) 1977-04-08

Family

ID=23035638

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7325355A Expired FR2263781B1 (US06724976-20040420-M00002.png) 1972-07-13 1973-07-11

Country Status (5)

Country Link
US (1) US3896218A (US06724976-20040420-M00002.png)
JP (1) JPS4962626A (US06724976-20040420-M00002.png)
CH (1) CH595104A5 (US06724976-20040420-M00002.png)
FR (1) FR2263781B1 (US06724976-20040420-M00002.png)
NL (1) NL7309699A (US06724976-20040420-M00002.png)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2335237A1 (fr) * 1975-12-19 1977-07-15 Pasteur Institut Vaccin contre l'hepatite virale de type b et procede de preparation de ce vaccin
FR2344629A1 (fr) * 1976-03-18 1977-10-14 Kabi Ab Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
FR2357899A1 (fr) * 1976-03-08 1978-02-03 Leuven Res & Dev Vzw Procede de purification d'un antiserum engendre a l'encontre d'un complexe enzyme-inhibiteur faisant partie du systeme de coagulation du sang ou du systeme fibrinolytique active dans le plasma sanguin
FR2486802A1 (fr) * 1980-07-21 1982-01-22 Merck & Co Inc Purification de l'antigene de surface de l'hepatite b (hbsag)
EP0727226A2 (de) * 1995-02-09 1996-08-21 BEHRINGWERKE Aktiengesellschaft Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
WO1997040861A1 (de) * 1996-04-30 1997-11-06 Immuno Aktiengesellschaft Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32696E (en) * 1975-09-04 1988-06-14 Akzona Incorporated Enzymatic immunological method for determination of antigens and antibodies
US4642285A (en) * 1975-09-29 1987-02-10 Diamedix Corporation Sandwich EIA for antigen
US4474878A (en) * 1975-09-29 1984-10-02 Cordis Laboratories, Inc. Sandwich EIA for antigen associated with hepatitis
US4038378A (en) * 1975-12-22 1977-07-26 Gyaneshwar Prasad Khare Radioimmunoassay for hepatitis b antigen
US4292296A (en) * 1978-09-12 1981-09-29 Baxter Travenol Laboratories, Inc. Diagnostic method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343949B (US06724976-20040420-M00002.png) * 1966-06-02 1972-03-20 Pharmacia Ab
SE337223B (US06724976-20040420-M00002.png) * 1967-05-23 1971-08-02 Pharmacia Ab

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2335237A1 (fr) * 1975-12-19 1977-07-15 Pasteur Institut Vaccin contre l'hepatite virale de type b et procede de preparation de ce vaccin
FR2357899A1 (fr) * 1976-03-08 1978-02-03 Leuven Res & Dev Vzw Procede de purification d'un antiserum engendre a l'encontre d'un complexe enzyme-inhibiteur faisant partie du systeme de coagulation du sang ou du systeme fibrinolytique active dans le plasma sanguin
FR2344629A1 (fr) * 1976-03-18 1977-10-14 Kabi Ab Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
FR2486802A1 (fr) * 1980-07-21 1982-01-22 Merck & Co Inc Purification de l'antigene de surface de l'hepatite b (hbsag)
EP0727226A2 (de) * 1995-02-09 1996-08-21 BEHRINGWERKE Aktiengesellschaft Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
EP0727226A3 (de) * 1995-02-09 1999-07-21 Centeon Pharma GmbH Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
WO1997040861A1 (de) * 1996-04-30 1997-11-06 Immuno Aktiengesellschaft Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
AU731048B2 (en) * 1996-04-30 2001-03-22 Immuno Aktiengesellschaft Biological material free of viral and molecular pathogens and a process for the production thereof

Also Published As

Publication number Publication date
JPS4962626A (US06724976-20040420-M00002.png) 1974-06-18
US3896218A (en) 1975-07-22
CH595104A5 (US06724976-20040420-M00002.png) 1978-01-31
FR2263781B1 (US06724976-20040420-M00002.png) 1977-04-08
NL7309699A (US06724976-20040420-M00002.png) 1974-01-15

Similar Documents

Publication Publication Date Title
DE3071183D1 (en) Latex reagent, process for its preparation, its application and an agent containing this reagent
GB1436934A (en) Method of testing blood
NL182175C (nl) Werkwijze voor het aantonen en kwantitatief bepalen van in biologische vloeistoffen aanwezige antigenen, antilichamen of antilichaam-antigeen-immuuncomplexen.
DE2963773D1 (en) Immunological determination process
FR2263781B1 (US06724976-20040420-M00002.png)
IL73437A (en) Method and test kit for detecting immune(clq)complexes in human serum by means of a mouse monoclonal antibody
DE3265768D1 (en) A method and a kit for the assay of antibodies to soluble antigens
CS312182A2 (en) Zpusob stanoveni reakce mezi antigenem a protilatkou a reakcni cinidlo k provadeni tohoto postupu
NL181461C (nl) Werkwijze en reagenskit voor het bepalen van antigenen, antilichamen of antigeen-antilichaam-complexen of -conjugaten.
JPS5516290A (en) Purified antigen for testing against neisseria gonorrhoeae antibody
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
NO843591L (no) Fremgangsmaate for aa bestemme pivka-ii-innhold i blodplasma og middel for utfoerelse av denne
ATE16219T1 (de) Immunologisches latex-agglutinationsverfahren.
SE7508003L (sv) Forfarande for pavisning av gonorreantikroppar
NL7606248A (nl) Werkwijze voor het aantonen van anti-lichamen in lichaamsvloeistoffen door middel van beken- de antigenen of voor het bepalen van antigenen door middel van uit lichaamsvloeistoffen afkom- stige antilichamen.
SE8205891D0 (sv) Alfa-l-antikropp och sett for framstellning derav
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
ATE14161T1 (de) Verfahren zur bestimmung von immunkomplexen.
JPS56129862A (en) Production of diagnosis latex reagent
GB1430461A (en) Purification of blood
JPS5716357A (en) Hbsag detecting reagent

Legal Events

Date Code Title Description
ST Notification of lapse